Sarah P. Lavoie is a member of Fasken's Intellectual Property and Life Sciences groups. She focuses primarily on the commercial and regulatory aspects of life sciences, and she is involved in preparing commercial contracts, actions for patent infringement, due diligence investigations of intellectual property assets, and drafting legal opinions on regulatory compliance in the pharmaceutical industry.
Sarah studied law and science at the Université de Sherbrooke, where she completed an undergraduate degree in Law, Life Sciences, and a master’s degree in Biology with a specialization in life sciences and law. Her master’s essay explored the concepts of utility and proper disclosure in Canadian patent law (Utilité et divulgation suffisante en droit canadien des brevets: comment prédire valablement les conséquences de l’affaire Raloxifène ?).